Synthesis and bio-assay of RCM-derived Bowman-Birk inhibitor analogues

Organic and Biomolecular Chemistry

Volumn 2, Issue 3, 2004, Pages 281-283

  Miles, Steven M ^a   Leatherbarrow, Robin J ^a   Marsden, Stephen P ^b   Coates, William J ^c  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF LEEDS   (United Kingdom)

^c GLAXOSMITHKLINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BIOASSAY; CARBON; MICROWAVES; PROTEINS; RESINS; STEREOCHEMISTRY; SULFUR COMPOUNDS; SYNTHESIS (CHEMICAL);

BOWMAN BIRK INHIBITOR ANALOGUES; CARBON ANALOGUES; CHYMOTRYPSIN; DISULFIDE; PEPTIDE; RING CLOSING METATHESIS;

AMINO ACIDS;

BOWMAN BIRK INHIBITOR; CHYMOTRYPSIN; CYCLOPEPTIDE; DISULFIDE;

ANIMAL; ARTICLE; CATTLE; CHEMICAL STRUCTURE; CHEMISTRY; DRUG ANTAGONISM; METABOLISM; SYNTHESIS;

ANIMALS; CATTLE; CHYMOTRYPSIN; DISULFIDES; MOLECULAR STRUCTURE; PEPTIDES, CYCLIC; TRYPSIN INHIBITOR, BOWMAN-BIRK SOYBEAN;

EID: 1342282240     PISSN: 14770520     EISSN: None     Source Type: Journal    
DOI: 10.1039/b312908j     Document Type: Article

References (30)

1. (a) P. Li, P. P. Roller and J. C. Xu, Curr. Org. Chem., 2002, 6, 411-440
2. (b) J. N. Lambert, J. P. Mitchell and K. D. Roberts, J. Chem. Soc., Perkin Trans. 1, 2001, 5, 471-484.
3. (a) A. Boruah, I. N. Rao, J. P. Nandy, S. K. Kumar, A. C. Kunwar and J. Iqbal, J. Org. Chem., 2003, 68, 5006-5008
4. (b) B. Banerji, B. Mallesham, S. K. Kumar, A. C. Kunwar and J. Iqbal, Tetrahedron Lett., 2002, 43, 6479-6483
5. (c) T. Sastry, B. Banerji, S. K. Kumar, A. C. Kunwar, J. Das, J. P. Nandy and J. Iqbal, Tetrahedron Lett., 2002, 43, 7621-7625
6. (d) H. E. Blackwell, J. D. Sadowsky, R. J. Howard, J. N. Sampson, J. A. Chao, W. E. Steinmatz, D. J. O'Leary and R. H. Grubbs, J. Org. Chem., 2001, 66, 5291-5302
7. (e) J. F. Reichwein, C. Versluis and R. M. J. Liskamp, J. Org. Chem., 2000, 65, 6187-6195
8. (f) C. E. Schafmeister, J. Po and G. L. Verdine, J. Am. Chem. Soc., 2000, 122, 5891-5892
9. (g) E. R. Jarvo, G. T. Copeland, N. Papaioannou, P. J. Bonitatebus and S. J. Miller, J. Am. Chem. Soc., 1999, 121, 11638-11643
10. (h) S. J. Miller, H. E. Blackwell and R. H. Grubbs, J. Am. Chem. Soc., 1996, 118, 9606-9614.
11. Y. Birk, Int. J. Peptide Protein Res., 1985, 25, 113-131.
12. A. B. E. Brauer, G. Kelly, J. D. McBride, R. M. Cooke, S. J. Matthews and R. J. Leatherbarrow, J. Mol. Biol., 2001, 306, 799-807.
13. (a) J. D. McBride, E. M. Watson, A. B. E. Brauer, A. M. Jaulent and R. J. Leatherbarrow, Biopolymers, 2002, 66, 79-92
14. (b) J. D. McBride, N. Freeman, G. J. Domingo and R. J. Leatherbarrow, J. Mol. Biol., 1996, 259, 819-827
15. (c) G. J. Domingo, R. J. Leatherbarrow, N. Freeman, S. Patel and M. Weir, Int. J. Pep. Prot. Res., 1995, 46, 79-87.
16. A known strategy for simpler peptides, see ref. 2h above.
17. Linear peptide precursors for the RCM reaction such as 2a were fully side-chain protected using the following standard protecting groups: Ser(tBu), Thr(tBu) and Gln(Trt).
18. +, 100%). ALl other RCM-derived peptides were synthesised similarly, with characterisation by FAB-MS and HPLC purity > 90%, and with olefins assumed to be a mixture of E and Z isomers (ratios not determined).
19. (a) C. M. Yang, W. V. Murray and L. J. Wilson, Tetrahedron Lett., 2003, 44, 1783-1786
20. (b) R. Grigg, W. Martin, J. Morris and V. Sridharan, Tetrahedron Lett., 2003, 44, 4899-4901
21. (c) J. Efskind and K. Undheim, Tetrahedron Lett., 2003, 44, 2837-2839
22. (d) K. G. Mayo, E. H. Nearhoof and J. J. Kiddle, Org. Lett., 2002, 4, 1567-1570.
23. Microwave-assisted RCM of a substrate bound to a soluble PEG support is known: S. Varray, C. Gauzy, F. Lamaty, R. Lazaro and J. Martinez, J. Org. Chem., 2000, 65, 6787-6790.
24. 8
25. N. J. Cusack, C. B. Reese, A. C. Risius and B. Rozpeikar, Tetrahedron, 1976, 32, 2157-2162.
26. i values quoted in Table 1 are the mean of two closely agreeing assays, except in the case of entries 1 and 7 when a single assay was performed. In the case of peptide 3a, hydrolysis assays were also performed to demonstrate the stability of the peptide under the assay conditions. Thus, peptide 3a was incubated with chymotrypsin (I : E ratio of 550 : 1) at 25°C and pH 7.8. Analytical HPLC of an aliquot after 30 min showed no detectable hydrolysis of 3a had occurred.
27. L. Hedstrom, J. J. Perona and W. J. Rutter, Biochemistry, 1994, 33, 8757-8763.
28. (a) P. G. Nantermet, J. C. Barrow, C. L. Newton, J. M. Pellicore, M. B. Young, S. D. Lewis, B. J. Lucas, J. A. Krueger, D. R. McMasters, Y. W. Yan, L. C. Kuo, J. P. Vacca and H. G. Selnick, Bioorg. Med. Chem. Lett., 2003, 13, 2781-2784
29. (b) Y. Gao, J. Voigt, J. X. Wu, D. J. Yang and T. R. Burke, Bioorg. Med. Chem. Lett., 2001, 11, 1889-1892
30. (c) A. S. Ripka, R. S. Bohacek and D. H. Rich, Bioorg. Med. Chem. Lett., 1998, 8, 357-360.